Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.

Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. Clin J Am Soc Nephrol. 2022 09; 17(9):1325-1336.

View in: PubMed

subject areas

Anemia
Double-Blind Method
Epoetin Alfa
Erythropoietin
Hematinics
Hemoglobins
Humans
Iron
Prolyl-Hydroxylase Inhibitors
Recombinant Proteins
Renal Dialysis
Renal Insufficiency, Chronic
Treatment Outcome

authors with profiles

Ajaypal Singh